These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 18328578)

  • 1. Current and future antiviral therapy of severe seasonal and avian influenza.
    Beigel J; Bray M
    Antiviral Res; 2008 Apr; 78(1):91-102. PubMed ID: 18328578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H; Kawai N
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
    Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
    Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology, clinical picture, prevention and treatment of Avian influenza].
    Angelava NA; Angelava AV
    Georgian Med News; 2006 Feb; (131):69-76. PubMed ID: 16575138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.
    Govorkova EA; Baranovich T; Seiler P; Armstrong J; Burnham A; Guan Y; Peiris M; Webby RJ; Webster RG
    Antiviral Res; 2013 May; 98(2):297-304. PubMed ID: 23458714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
    Hurt AC; Selleck P; Komadina N; Shaw R; Brown L; Barr IG
    Antiviral Res; 2007 Mar; 73(3):228-31. PubMed ID: 17112602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture].
    Fediakina IT; Shchelkanov MIu; Deriabin PG; Leneva IA; Gudova NV; Kondrat'eva TV; L'vov DK
    Antibiot Khimioter; 2011; 56(3-4):3-9. PubMed ID: 21913403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraminidase inhibitors and their role in avian and pandemic influenza.
    Crusat M; de Jong MD
    Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.
    McKimm-Breschkin JL
    Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):25-36. PubMed ID: 23279894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudovirus-based neuraminidase inhibition assays reveal potential H5N1 drug-resistant mutations.
    Lu Y; Jiang T
    Protein Cell; 2013 May; 4(5):356-63. PubMed ID: 23589018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Susceptibilities of Avian Influenza A(H5), A(H7), and A(H9) Viruses Isolated in Japan.
    Takashita E; Morita H; Nagata S; Shirakura M; Fujisaki S; Miura H; Takayama I; Arita T; Suzuki Y; Yamaoka M; Tanikawa T; Tsunekuni R; Mine J; Sakuma S; Uchida Y; Shibata A; Iwanaka M; Kishida N; Nakamura K; Kageyama T; Watanabe S; Hasegawa H;
    Jpn J Infect Dis; 2022 Jul; 75(4):398-402. PubMed ID: 34980710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of H5N1 avian influenza viruses in Asia.
    World Health Organization Global Influenza Program Surveillance Network
    Emerg Infect Dis; 2005 Oct; 11(10):1515-21. PubMed ID: 16318689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention.
    De Clercq E; Neyts J
    Trends Pharmacol Sci; 2007 Jun; 28(6):280-5. PubMed ID: 17481739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.
    Deyde VM; Nguyen T; Bright RA; Balish A; Shu B; Lindstrom S; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1039-47. PubMed ID: 19124660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the structure-based design of the influenza A neuraminidase inhibitors.
    Mitrasinovic PM
    Curr Drug Targets; 2010 Mar; 11(3):315-26. PubMed ID: 20210756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses.
    Govorkova EA
    Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):50-7. PubMed ID: 23279897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
    Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL
    J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
    Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
    Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.